The clinical impact of CYP2C19 *2 and *3 polymorphism on Clopidogrel and cost analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2164
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The clinical impact of CYP2C19 *2 and *3 polymorphism on Clopidogrel and cost analysis ; volume:15 ; number:2 ; day:2 ; month:4 ; year:2014 ; pages:1 ; date:4.2014
BMC genomics ; 15, Heft 2 (2.4.2014), 1, 4.2014
- Creator
-
Meman A, Al
- Contributor
-
H, Khalaf
Seemab, Rasool
SpringerLink (Online service)
- DOI
-
10.1186/1471-2164-15-S2-P19
- URN
-
urn:nbn:de:1111-201607299250
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Meman A, Al
- H, Khalaf
- Seemab, Rasool
- SpringerLink (Online service)
Other Objects (12)
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study
The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study
Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice
Mixture of clopidogrel bisulfate and magnesium oxide tablets reduces clopidogrel dose administered through a feeding tube
Application of Genetic Testing for CYP 450 Polymorphism to Predict Response to Clopidogrel Inpatient Undergoing PCI
The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati population
Clopidogrel induced autoimmune hypoglycemia
The impact of CYP2C19 *2 and *3 polymorphism on clopidogrel response following coronary stenting in Saudi patients with acute coronary syndrome
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study
The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study
Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice
Mixture of clopidogrel bisulfate and magnesium oxide tablets reduces clopidogrel dose administered through a feeding tube
Application of Genetic Testing for CYP 450 Polymorphism to Predict Response to Clopidogrel Inpatient Undergoing PCI
The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati population
Clopidogrel induced autoimmune hypoglycemia
The impact of CYP2C19 *2 and *3 polymorphism on clopidogrel response following coronary stenting in Saudi patients with acute coronary syndrome
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study
The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study
Impact of CYP3A4*1G Allele on Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice
Mixture of clopidogrel bisulfate and magnesium oxide tablets reduces clopidogrel dose administered through a feeding tube
Application of Genetic Testing for CYP 450 Polymorphism to Predict Response to Clopidogrel Inpatient Undergoing PCI
The diversity and clinical implications of genetic variants influencing clopidogrel bioactivation and response in the Emirati population
Clopidogrel induced autoimmune hypoglycemia